The diverse role of TIGAR in cellular homeostasis and cancer

References

• Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–707.
   PubMed Web of Science ®Google Scholar
• Schmitt CA, Fridman JS, Yang M, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 2002;109:335–346.
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010–1014.
   PubMed Web of Science ®Google Scholar
• Matoba S, Kang JG, Patino WD, et al. p53 regulates mitochondrial respiration. Science. 2006;312:1650–1653.
   PubMed Web of Science ®Google Scholar
• Crighton D, Wilkinson S, O’Prey J, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 2006;126:121–134.
   PubMed Web of Science ®Google Scholar
• Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006;126:107–120.
   PubMed Web of Science ®Google Scholar
• Cheung EC, Ludwig RL, Vousden KH. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc Natl Acad Sci USA. 2012;109:20491–20496.
   PubMed Web of Science ®Google Scholar
• Wang CK, Ahmed MM, Jiang Q, et al. Melatonin ameliorates hypoglycemic stress-induced brain endothelial tight junction injury by inhibiting protein nitration of TP53-induced glycolysis and apoptosis regulator. J Pineal Res. 2017;63:e12440.
   PubMed Web of Science ®Google Scholar
• Li H, Jogl G. Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J Biol Chem. 2009;284:1748–1754.
   PubMed Web of Science ®Google Scholar
• Gerin I, Noël G, Bolsée J, et al. Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase. Biochem J. 2014;458:439–448.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan R, Roy A, et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12:7–8.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Li D, Ou Y, et al. Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep. 2016;17:366–373.
   PubMed Web of Science ®Google Scholar
• Lee P, Hock AK, Vousden KH, Cheung EC. p53- and p73-independent activation of TIGAR expression in vivo. Cell Death Dis. 2015;6:e1842.
   PubMed Web of Science ®Google Scholar
• Li M, Sun M, Cao L, et al. A TIGAR-regulated metabolic pathway is critical for protection of brain ischemia. J Neurosci. 2014;34:7458–7471.
   PubMed Web of Science ®Google Scholar
• Zou S, Wang X, Deng L, et al. CREB, another culprit for TIGAR promoter activity and expression. Biochem Biophys Res Commun. 2013;439:481–486.
   PubMed Web of Science ®Google Scholar
• Zou S, Gu Z, Ni P, et al. SP1 plays a pivotal role for basal activity of TIGAR promoter in liver cancer cell lines. Mol Cell Biochem. 2012;359:17–23.
   PubMed Web of Science ®Google Scholar
• Rajendran R, Arva R, Ashour H, et al. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer. Int J Oncol. 2013;42:1961–1972.
   PubMed Web of Science ®Google Scholar
• Xu X, Liu C, Bao J. Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma. Mol Med Rep. 2017;15:1373–1378.
   PubMed Web of Science ®Google Scholar
• Chen S, Li P, Li J, et al. MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR. Cell Physiol Biochem. 2015;35:997–1007.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen J, Li M, et al. Endogenous level of TIGAR in brain is associated with vulnerability of neurons to ischemic injury. Neurosci Bull. 2015;31:527–540.
   PubMed Web of Science ®Google Scholar
• Yu HP, Xie JM, Li B, et al. TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway. Sci Rep. 2015;5:9853.
   PubMed Web of Science ®Google Scholar
• Rigden DJ. The histidine phosphatase superfamily: structure and function. Biochem J. 2008;409:333–348.
   PubMed Web of Science ®Google Scholar
• Monge L, Mojena M, Ortega JL, et al. Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes. 1986;35:89–96.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Gil JE, Gómez-Foix AM, Fillat C, et al. Activation by vanadate of glycolysis in hepatocytes from diabetic rats. Diabetes. 1991;40:1355–1359.
   PubMed Web of Science ®Google Scholar
• Choi IY, Wu C, Okar DA, et al. Elucidation of the role of fructose 2,6-bisphosphate in the regulation of glucose fluxes in mice using in vivo 13C NMR measurements of hepatic carbohydrate metabolism. FEBS J. 2002;269:4418–4426.
   Google Scholar
• Wu C, Khan SA, Peng LJ, et al. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab. 2006;291:E536–E543.
   PubMed Web of Science ®Google Scholar
• Derdak Z, Lang CH, Villegas KA, et al. Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol. 2011;54:164–172.
   PubMed Web of Science ®Google Scholar
• Qi Z, He J, Zhang Y, et al. Exercise training attenuates oxidative stress and decreases p53 protein content in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. Free Radic Biol Med. 2011;50:794–800.
   PubMed Web of Science ®Google Scholar
• Sun M, Li M, Huang Q, et al. Ischemia/reperfusion-induced upregulation of TIGAR in brain is mediated by SP1 and modulated by ROS and hormones involved in glucose metabolism. Neurochem Int. 2015;80:99–109.
   PubMed Web of Science ®Google Scholar
• Zhou JH, Zhang TT, Song DD, et al. TIGAR contributes to ischemic tolerance induced by cerebral preconditioning through scavenging of reactive oxygen species and inhibition of apoptosis. Sci Rep. 2016;6:27096.
   PubMed Web of Science ®Google Scholar
• Jiang LB, Cao L, Ma YQ, et al. TIGAR mediates the inhibitory role of hypoxia on ROS production and apoptosis in rat nucleus pulposus cells. Osteoarthritis Cartilage. 2017;26:138–148.
   Web of Science ®Google Scholar
• Kim J, Devalaraja-Narashimha K, Padanilam BJ. TIGAR regulates glycolysis in ischemic kidney proximal tubules. Am J Physiol Renal Physiol. 2015;308:F298–F308.
   PubMed Web of Science ®Google Scholar
• Meng J, Lv Z, Qiao X, et al. The decay of Redox-stress Response Capacity is a substantive characteristic of aging: revising the redox theory of aging. Redox Biol. 2017;11:365–374.
   PubMed Web of Science ®Google Scholar
• Flinn LJ, Keatinge M, Bretaud S, et al. TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency. Ann Neurol. 2013;74:837–847.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Matoba S, Iwai-Kanai E, et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol. 2012;52:175–184.
   PubMed Web of Science ®Google Scholar
• Kimata M, Matoba S, Iwai-Kanai E, et al. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am J Physiol Heart Circ Physiol. 2010; 299:H1908–H1916.
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Trimmer C, Lin Z, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle. 2010;9:3515–3533.
   PubMed Web of Science ®Google Scholar
• Qian S, Li J, Hong M, et al. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia. J Hematol Oncol. 2016;9:128.
   PubMed Web of Science ®Google Scholar
• Kumar B, Iqbal MA, Singh RK, et al. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie. 2015;118:26–35.
   PubMed Web of Science ®Google Scholar
• Venkatanarayan A, Raulji P, Norton W, et al. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73. Cell Cycle. 2016;15:164–171.
   PubMed Web of Science ®Google Scholar
• Hong M, Xia Y, Zhu Y, et al. TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia. Leuk Res. 2016;50:72–77.
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Yamada Y, Iha H, et al. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells. Leukemia. 2009;23:2090–2101.
   PubMed Web of Science ®Google Scholar
• Wong E, Wong SC, Chan C, et al. TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells. Oncol Lett. 2015;9:569–574.
   PubMed Web of Science ®Google Scholar
• Zhao M, Fan J, Liu Y, et al. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation. Int J Oncol. 2016;48:756–764.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xie W, Li Q, et al. TIGAR is correlated with maximal standardized uptake value on FDG-PET and survival in non-small cell lung cancer. PLoS One. 2013;8:e80576.
   PubMed Web of Science ®Google Scholar
• Won KY, Lim SJ, Kim GY, et al. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Hum Pathol. 2012;43:221–228.
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Goldberg AF, Lin Z, et al. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biol Ther. 2011;12:924–938.
   PubMed Web of Science ®Google Scholar
• Lin CC, Cheng TL, Tsai WH, et al. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep. 2012;2:785.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi SI, Won KY, et al. Distinctive interrelation of p53 with SCO2, COX, and TIGAR in human gastric cancer. Pathol Res Pract. 2016;212:904–910.
   PubMed Web of Science ®Google Scholar
• Rajeshkumar NV, Dutta P, Yabuuchi S, et al. Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function. Cancer Res. 2015;75:3355–3364.
   PubMed Web of Science ®Google Scholar
• Dai Q, Yin Y, Liu W, et al. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. Int J Biochem Cell Biol. 2013;45:1468–1478.
   PubMed Web of Science ®Google Scholar
• Liu S, Yan B, Lai W, et al. As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect. Biochim Biophys Acta. 2014;1839:592–603.
   PubMed Web of Science ®Google Scholar
• Al-Khayal K, Abdulla M, Al-Obeed O, et al. Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients. Oncol Rep. 2016;35:1281–1286.
   PubMed Web of Science ®Google Scholar
• Chesney J, Mitchell R, Benigni F, et al. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA. 1999;96:3047–3052.
   PubMed Web of Science ®Google Scholar
• Ma R, Zhang W, Tang K, et al. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun. 2013;4:2508.
   PubMed Web of Science ®Google Scholar
• Ros S, Flöter J, Kaymak I, et al. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells. Oncogene. 2017;36:3287–3299.
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Rajapakshe K, Zhu B, et al. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature. 2018;556:249–254.
   PubMed Web of Science ®Google Scholar
• Pavlides S, Whitaker-Menezes D, Castello-Cros R, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8:3984–4001.
   PubMed Web of Science ®Google Scholar
• Ko YH, Domingo-Vidal M, Roche M, et al. TP53-inducible glycolysis and apoptosis regulator (TIGAR) metabolically reprograms carcinoma and stromal cells in breast cancer. J Biol Chem. 2016;291:26291–26303.
   PubMed Web of Science ®Google Scholar
• Shi XY, Xiong LX, Xiao L, et al. Downregulation of caveolin-1 upregulates the expression of growth factors and regulators in co-culture of fibroblasts with cancer cells. Mol Med Rep. 2016;13:744–752.
   PubMed Web of Science ®Google Scholar
• Wanka C, Steinbach JP, Rieger J. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis. J Biol Chem. 2012;287:33436–33446.
   PubMed Web of Science ®Google Scholar
• Simon-Molas H, Calvo-Vidal MN, Castaño E, et al. Akt mediates TIGAR induction in HeLa cells following PFKFB3 inhibition. FEBS Lett. 2016;590:2915–2926.
   PubMed Web of Science ®Google Scholar
• Ghildiyal R, Sen E. CK2 induced RIG-I drives metabolic adaptations in IFNγ-treated glioma cells. Cytokine. 2017;89:219–228.
   PubMed Web of Science ®Google Scholar
• Cheung EC, Athineos D, Lee P, et al. TIGAR is required for efficient intestinal regeneration and tumorigenesis. Dev Cell. 2013;25:463–477.
   PubMed Web of Science ®Google Scholar
• Cheung EC, Lee P, Ceteci F, et al. Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestine. Genes Dev. 2016;30:52–63.
   PubMed Web of Science ®Google Scholar
• Qi Z, He Q, Ji L, et al. Antioxidant supplement inhibits skeletal muscle constitutive autophagy rather than fasting-induced autophagy in mice. Oxid Med Cell Longev. 2014;2014:315896.
   PubMedGoogle Scholar
• Kim SJ, Jung HJ, Lim CJ. Reactive oxygen species-dependent down-regulation of tumor suppressor genes PTEN, USP28, DRAM, TIGAR, and CYLD under oxidative stress. Biochem Genet. 2013;51:901–915.
   PubMed Web of Science ®Google Scholar
• Bensaad K, Cheung EC, Vousden KH. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009;28:3015–3026.
   PubMed Web of Science ®Google Scholar
• Xie JM, Li B, Yu HP, et al. TIGAR has a dual role in cancer cell survival through regulating apoptosis and autophagy. Cancer Res. 2014;74:5127–5138.
   PubMed Web of Science ®Google Scholar
• Ye L, Zhao X, Lu J, et al. Knockdown of TIGAR by RNA interference induces apoptosis and autophagy in HepG2 hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2013;437:300–306.
   PubMed Web of Science ®Google Scholar
• Ko YH, Lin Z, Flomenberg N, et al. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance. Cancer Biol Ther. 2011;12:1085–1097.
   PubMed Web of Science ®Google Scholar
• Wang J, Duan Z, Nugent Z, et al. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes. Cancer Lett. 2016;378:69–79.
   PubMed Web of Science ®Google Scholar
• Martinez-Marignac V, Toban N, Bazile M, et al. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming. Oncotarget. 2013;4:2550–2566.
   PubMedGoogle Scholar
• Zhang H, Gu C, Yu J, et al. Radiosensitization of glioma cells by TP53-induced glycolysis and apoptosis regulator knockdown is dependent on thioredoxin-1 nuclear translocation. Free Radic Biol Med. 2014;69:239–248.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen F, Tai G, et al. TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport. Sci Rep. 2017;7:42928.
   PubMed Web of Science ®Google Scholar
• Yin L, Kosugi M, Kufe D. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH. Blood. 2012;119:810–816.
   PubMed Web of Science ®Google Scholar
• Nutt LK, Margolis SS, Jensen M, et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell. 2005;123:89–103.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345–19350.
   PubMed Web of Science ®Google Scholar
• Yin L, Kufe T, Avigan D, et al. Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death. Blood. 2014;123:2997–3006.
   PubMed Web of Science ®Google Scholar
• Jain S, Stroopinsky D, Yin L, et al. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2015;126:354–362.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Sinha RK, Kumar M, et al. Intracellular targeting of the oncogenic MUC1-C protein with a novel GO-203 nanoparticle formulation. Clin Cancer Res. 2015;21:2338–2347.
   PubMed Web of Science ®Google Scholar
• Ahmad R, Alam M, Hasegawa M, et al. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer. Mol Cancer. 2017;16:33.
   PubMed Web of Science ®Google Scholar
• Peña-Rico MA, Calvo-Vidal MN, Villalonga-Planells R, et al. TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells. Radiother Oncol. 2011;101:132–139.
   PubMed Web of Science ®Google Scholar
• Iwao C, Shidoji Y. Upregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatment. Biomed Res. 2015;36:371–381.
   PubMed Web of Science ®Google Scholar
• Madan E, Gogna R, Kuppusamy P, et al. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex. Br J Cancer. 2012;107:516–526.
   PubMed Web of Science ®Google Scholar